Zhengye Biotechnology Holding Limited

NASDAQ:ZYBT

Drug Manufacturers - Specialty & Generic

Healthcare
$1.50 +1047.56%

+$7.31 today

Market cap
$71.09M
Beta
-2.17
P/E (TTM)
-36.3
EPS (TTM)
-$1.50
52W Low $0.62High $13.08

Volume 0.02M

Average 0.10M

Balance Sheet

Inspect the capital base behind the business.

Assets

$436.47M

FY 2025 · Annual

-11.5% YoY

Liabilities

$129.76M

FY 2025 · Annual

-7.8% YoY

Equity

$306.71M

FY 2025 · Annual

-13.0% YoY

Balance Sheet

CNY
Metric
FY2021
Dec 2021
FY2022
Dec 2022
FY2023
Dec 2023
FY2024
Dec 2024
FY2025
Dec 2025
Cash & Equivalents6.28M9.75M15.07M18.6M50.33M
Short-term Investments001.22M1.43M1.56M
Net Receivables102.19M134.25M99.42M88.52M18.49M
Inventory43.62M55.42M58.3M58.22M39.17M
Other Current Assets11.14M12.46M24.03M2K6.78M
Total Current Assets164.94M214.31M205.59M177.57M137.42M
Property, Plant & Equipment (Net)255.12M283.67M271.5M255.16M237.28M
Goodwill00000
Intangible Assets12.05M19.46M16.3M22.78M54.76M
Long-term Investments00000
Tax Assets00010.99M0
Other Non-current Assets13.17M2.23M6.5M26.75M7.01M
Total Non-current Assets280.34M305.37M294.3M315.68M299.05M
Total Assets445.28M519.67M499.89M493.25M436.47M
Account Payables77.57M79.28M45.66M42.96M44.01M
Short-term Debt30M54.89M79.86M81.63M65.8M
Tax Payables6.81M10M2.3M2.07M2.35M
Deferred Revenue4.28M4.7M3.99M3.69M4.83M
Other Current Liabilities0003.28M397K
Total Current Liabilities125.63M152.23M150.23M135.91M120.48M
Long-term Debt09.99M9.99M4.8M8.85M
Deferred Tax Liabilities0000104K
Deferred Revenue (Non-current)00000
Other Non-current Liabilities816K590K393K00
Total Non-current Liabilities816K10.58M10.38M4.8M9.28M
Total Liabilities126.44M162.81M160.62M140.71M129.76M
Common Stock8K8K8K8K8K
Retained Earnings42.33M65.77M38.38M48.15M(21.63M)
Accumulated OCI21.99M27.57M31.31M32.65M30.72M
Other Stockholders Equity00000
Minority Interest51.36M60.37M66.42M68.58M56.87M
Total Equity318.84M356.87M339.27M352.54M306.72M
Total Debt30M64.88M89.85M86.43M75.08M
Net Debt23.72M55.13M74.78M67.83M24.75M

Balance Sheet

Assets, liabilities & equity

Cash & Equivalents$50.3M
Short-term Investments$1.6M
Receivables$18.5M
Inventory$39.2M
Other Current$27.9M
Total Current Assets$137.4M
PP&E (Net)$237.3M
Intangible Assets$54.8M
Other Non-current$7.0M
Total Non-current Assets$299.1M
Total Assets$436.5M

Analysis

Selected assets total $436.5M for Latest. The largest visible component is PP&E (Net) at $237.3M, about 54.4% of the tab total. Use the mix to judge balance sheet concentration, liquidity, leverage, and how much of book value is supported by tangible operating assets.

Recent Filings

Recent regulatory filings

FilingDescriptionDate
6-K6-K filingNov 12, 2026
6-K6-K filingAug 6, 2026
6-K6-K filingJul 21, 2026
3Initial statement of beneficial ownershipJun 25, 2026
3Initial statement of beneficial ownershipJun 25, 2026

How much cash does ZYBT have?

Zhengye Biotechnology Holding Limited (ZYBT) reported $50.33M in cash and equivalents in fiscal 2025.

How much debt does ZYBT carry?

Zhengye Biotechnology Holding Limited (ZYBT) reported $75.08M of total debt, with net debt of $24.75M.